Reliance Chemotex Industries Ltd-$
Reliance Chemotex Industries Ltd-$ (RELCHEMQ) last reported results for the quarter ended Jun 2026, with sales of ₹98.82 crore and net profit of ₹1.37 crore. The stock last traded at ₹114, a market capitalisation of ₹83.2 crore, on a P/E of 15.0. Over the past 52 weeks the stock has ranged between ₹105 and ₹171. Figures are as of 9 Oct 2026 and are not real time.
Reliance Chemotex Industries Ltd-$ share price and key metrics
- Current price
- ₹114
- Market cap
- ₹83.2 cr
- Stock P/E
- 15.0
- Book value
- ₹189
- ROE
- 3.53%
- ROCE
- 7.27%
- Dividend yield
- 0.44%
- 52w high / low
- 171/105
Metrics as of 9 Oct 2026. Not real time.
Track Reliance Chemotex Industries Ltd-$
Cruxal reads every Reliance Chemotex Industries Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Reliance Chemotex Industries Ltd-$ growth and returns
- 10 Years
- 3%
- 5 Years
- 7%
- 3 Years
- 0%
- TTM
- 3%
- 10 Years
- 7%
- 5 Years
- -7%
- 3 Years
- -27%
- TTM
- 24%
- 10 Years
- 6%
- 5 Years
- -6%
- 3 Years
- -20%
- 1 Year
- -27%
- 10 Years
- 7%
- 5 Years
- 7%
- 3 Years
- 3%
- Last Year
- 4%
Reliance Chemotex Industries Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹98.82 cr, up 7.0% from ₹92.36 cr a year earlier. Net profit was ₹1.37 cr, up 29.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 91.6 | 92.23 | 82.2 | 92.36 | 99.52 | 81.94 | 88.18 | 98.82 |
| Expenses | 85.51 | 83.26 | 70.84 | 81.6 | 89.24 | 71.24 | 79.21 | 88.03 |
| Operating profit | 6.09 | 8.97 | 11.36 | 10.76 | 10.28 | 10.7 | 8.97 | 10.79 |
| OPM % | 6.65% | 9.73% | 13.82% | 11.65% | 10.33% | 13.06% | 10.17% | 10.92% |
| Other income | 3.75 | 0.56 | 1.72 | 0.39 | 0.36 | 0.4 | 2.68 | 0.9 |
| Interest | 6.03 | 5.91 | 5.83 | 6.5 | 5.88 | 6.32 | 6.21 | 6.76 |
| Depreciation | 3.48 | 3.5 | 4.22 | 3.69 | 3.7 | 3.7 | 3.7 | 3.63 |
| Profit before tax | 0.33 | 0.12 | 3.03 | 0.96 | 1.06 | 1.08 | 1.74 | 1.3 |
| Tax % | -327.27% | -58.33% | 38.94% | -11.46% | -55.66% | 25.93% | -0.57% | -5.38% |
| Net profit | 1.42 | 0.19 | 1.84 | 1.06 | 1.65 | 0.8 | 1.75 | 1.37 |
| EPS (₹) | 1.88 | 0.25 | 2.44 | 1.41 | 2.19 | 1.06 | 2.32 | 1.82 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Reliance Chemotex Industries Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 291 | 285 | 323 | 300 | 256 | 362 | 364 | 366 | 357 | 360 | 368 |
| Operating profit | 22 | 19 | 26 | 28 | 23 | 45 | 35 | 31 | 32 | 41 | 41 |
| OPM % | 8% | 7% | 8% | 9% | 9% | 12% | 10% | 8% | 9% | 11% | 11% |
| Net profit | 6 | 3 | 4 | 9 | 7 | 18 | 12 | 3 | 4 | 5 | 6 |
| EPS (₹) | 8.10 | 3.25 | 5.11 | 12.37 | 9.19 | 24.03 | 16.46 | 4.26 | 5.37 | 6.97 | 7.39 |
TTM is the trailing twelve months to the most recent quarter.
Reliance Chemotex Industries Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 4 | 4 | 4 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 64 | 66 | 63 | 91 | 97 | 114 | 124 | 126 | 130 | 135 |
| Borrowings | 95 | 94 | 82 | 65 | 97 | 128 | 199 | 281 | 263 | 268 |
| Other liabilities | 64 | 63 | 69 | 65 | 61 | 84 | 66 | 66 | 74 | 102 |
| Total liabilities | 227 | 228 | 218 | 227 | 263 | 333 | 397 | 481 | 474 | 512 |
| Fixed assets | 152 | 145 | 140 | 136 | 148 | 181 | 196 | 318 | 313 | 299 |
| CWIP | 0 | 0 | 0 | 6 | 1 | 10 | 39 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 76 | 82 | 79 | 85 | 113 | 142 | 162 | 163 | 162 | 213 |
| Total assets | 227 | 228 | 218 | 227 | 263 | 333 | 397 | 481 | 474 | 512 |
As reported by the company. Total assets equal total liabilities by construction.
Reliance Chemotex Industries Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 32 | 11 | 26 | 22 | 27 | 59 | -0 | 18 | 11 | 22 |
| Cash from investing | -2 | -0 | -0 | -8 | -43 | -74 | -51 | -82 | 33 | -2 |
| Cash from financing | -30 | -11 | -26 | -13 | 15 | 14 | 55 | 60 | -43 | -20 |
| Net cash flow | -0 | -1 | -0 | 1 | -0 | -0 | 4 | -4 | 0 | -0 |
| Free cash flow | 28 | 10 | 25 | 15 | 12 | 9 | -54 | -75 | 2 | 21 |
| CFO / operating profit | 152% | 62% | 105% | 83% | 118% | 140% | 7% | 62% | 32% | 54% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Reliance Chemotex Industries Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 12% | 8% | 13% | 14% | 11% | 19% | 11% | 7% | 7% | 7% |
| Debtor days | 23 | 22 | 20 | 16 | 15 | 5 | 7 | 6 | 18 | 10 |
| Inventory days | 85 | 97 | 74 | 82 | 138 | 91 | 87 | 104 | 145 | 224 |
| Days payable | 79 | 84 | 70 | 65 | 58 | 57 | 28 | 32 | 58 | 55 |
| Cash conversion cycle | 30 | 36 | 24 | 33 | 95 | 40 | 67 | 78 | 105 | 179 |
| Working capital days | -19 | -22 | -11 | -12 | -42 | -62 | -81 | -58 | -27 | -1 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Reliance Chemotex Industries Ltd-$ shareholding pattern
Promoters held 67.69% at Sep 2026, broadly unchanged since Sep 2025. FIIs 0.00% and DIIs 0.00%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.69% | 67.69% | 67.69% | 67.69% | 67.69% | 67.69% | 67.69% | 67.69% |
| FIIs | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 32.31% | 32.32% | 32.27% | 32.32% | 32.32% | 32.33% | 32.32% | 32.32% |
| No. of shareholders | 12,649 | 12,858 | 13,064 | 13,133 | 13,133 | 13,166 | 13,156 | 13,281 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Reliance Chemotex Industries Ltd-$ corporate filings
- Certificate under reg. 74(5) of SEBI (DP) regulations, 2018 for the period ended on September 30, 2026Company Updatelow impact
- Trading window closure for Un-audited Financial Results for the quarter and half year ended on September 30, 2026Insider Trading / SASTlow impact
- Reliance Chemotex Industries Ltd. Announces Successful Conclusion of 48th AGM and Re-appointment of Key LeadershipCompany Updatelow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd. has successfully concluded its 48th Annual General…
Read the full analysis - Reliance Chemotex Industries Ltd. concludes 48th AGM; shareholders approve final dividend of INR 0.50 per shareAGM/EGMlow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd. has successfully concluded its 48th Annual General…
Read the full analysis - Reliance Chemotex Industries Ltd. Concludes 48th Annual General Meeting; Approves Final Dividend of INR 0.50 per ShareAGM/EGMlow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd. has successfully concluded its 48th Annual General…
Read the full analysis - Reliance Chemotex Industries Ltd announces newspaper publication for 48th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd has completed the mandatory newspaper publication…
Read the full analysis - Reliance Chemotex Industries Ltd releases Annual Report for F.Y. 2025-26Otherslow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd has filed its Annual Report for the financial year…
Read the full analysis - Reliance Chemotex Industries Limited Announces Annual Report 2025-26 and Final Dividend of INR 0.50 per shareAGM/EGMhigh impact
Cruxal's analysis: Reliance Chemotex Industries Limited has released its Annual Report for FY 2025-26…
Read the full analysis - Reliance Chemotex Industries Ltd: Newspaper Publication of Financial ResultsCompany Updatelow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd has published its financial results in newspapers as per…
Read the full analysis - Reliance Chemotex Industries Ltd publishes statutory newspaper noticeCompany Updatelow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd has fulfilled its regulatory obligation under Regulation…
Read the full analysis - Reliance Chemotex Industries announces re-appointment of Mr. Sanjiv Shroff as Managing Director for a three-year termCompany Updatelow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd. has formally announced the re-appointment of Mr. Sanjiv…
Read the full analysis - Reliance Chemotex Industries Ltd. announces Book Closure and Record Date for 48th AGM and Dividend paymentCorp. Actionlow impact
Cruxal's analysis: Reliance Chemotex Industries Ltd. has formally notified the exchanges regarding the…
Read the full analysis - Reliance Chemotex Industries reports Q1 FY27 results with 7% YoY revenue growth and announces MD re-appointmentBoard Meetinghigh impact
Cruxal's analysis: Reliance Chemotex Industries Limited reported Q1 FY27 revenue from operations of 98.82…
Read the full analysis - Reliance Chemotex Industries reports Q1 FY27 net profit of 1.37 crore, reflecting 28.5% YoY growthResulthigh impact
Cruxal's analysis: Reliance Chemotex Industries Limited reported revenue from operations of 98.82 crore for…
Read the full analysis - Reliance Chemotex Industries schedules Board Meeting for August 11, 2026, to approve Q1 FY27 results and AGM agendaBoard Meetinglow impact
Cruxal's analysis: Reliance Chemotex Industries has announced a Board Meeting scheduled for August 11, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.